Industry News

Arasan expands Total MIPI Display IP with seamlessly integrated VESA DSC IP

SAN JOSE, Calif., Jan. 29, 2022 /PRNewswire/ -- Arasan Chip Systems, the leading provider of Total IPTM for the SoC market announces the launch of its MIPI DSI-2SM with its seamlessly integrated VESA DSC IP. The VESA DSC IP is compliant with the VESA DSC 1.2 Specifications. Arasan's Total MIPI D...

2022-01-29 06:35 6149

MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

BEIJING, Jan. 28, 2022 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), aChina-based technology company that provides access to the U.S. financial markets, today announced that onJanuary 26, 2022,t he Company received a notification letter (the "Notification Lett...

2022-01-29 06:00 7075

RECORD-BREAKING CAMPAIGN LAUNCH FOR BOSS AND HUGO - COVERAGE WITH ALMOST 2 BILLION IMPRESSIONS IN 1 DAY

METZINGEN, Germany, Jan. 29, 2022 /PRNewswire/ -- HUGO BOSS successfully kicked off its brand refresh, following its new growth strategy, with the simultaneous launch of the two star-studded global campaigns for its brands BOSS and HUGO on January 26. Together, the two global campaigns gained a co...

2022-01-29 05:32 7065

EMPIRE STATE BUILDING TO CELEBRATE LUNAR NEW YEAR WITH VIRTUAL TOWER LIGHTING CEREMONY AND FESTIVE FIFTH AVENUE LOBBY WINDOW DISPLAY

To celebrate the Year of the Tiger, the building will shine red for its 22nd consecutive year NEW YORK, Jan. 29, 2022 /PRNewswire/ -- The Empire State Building (ESB) today announced a Lunar New Year celebration onJan. 30 with a virtual lighting ceremony and reveal of a new, festive Fifth Avenue ...

2022-01-29 05:30 7542

Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China

BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 29, 2022 /PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the two compan...

2022-01-29 05:28 4902

Organic fireworks SPARK as a new sustainable celebration

ROTTERDAM, Netherlands, Jan. 29, 2022 /PRNewswire/ -- How can we celebrate sustainably? Artist Daan Roosegaarde became inspired by the magical light of fireflies, and a desire to update the culturally ingrained ritual of fireworks. The result is SPARK Bilbao, a poetic performance of thousands of ...

2022-01-29 05:12 5123

Corporate Compliance Services set to go Digital in Singapore: HeySara's FAST App will empower entrepreneurs to be more efficient with a new digital platform

SINGAPORE, Jan. 28, 2022 /PRNewswire/ -- HeySara, the leading innovator in the Corporate Compliance space is proud to announce the launch of the FAST App. The FAST, which is the acronym for Financial, Analytics, Secretarial Services, and Taxation, will empower entrepreneurs to simplify their comp...

2022-01-28 23:27 5115

Bon Natural Life Limited Announces FY2021 Earnings Release Date and Webcast

* Earnings to be released before market opens on Monday, January 31, 2022 XI'AN, China, Jan. 28, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will ...

2022-01-28 22:00 6775

CTB001, Bioheng auto CAR - T Product, received Orphan Drug Designation (ODD) from the U.S. FDA

NANJING, China, Jan. 28, 2022 /PRNewswire/ -- Recently, Nanjing Bioheng Biotech Co.,Ltd. ( hereinafter referred to as Bioheng) announced that its anti-claudin 18.2 autologous CAR-T cell therapy product CTB001 received Orphan Drug Designation (ODD) from the Food and Drug Administration (FDA) for t...

2022-01-28 22:00 3819

Yunji's Private Label Food Brands Are a Hit With Members During 2022 Online Lunar New Year Shopping Festival

HANGZHOU, China, Jan. 28, 2022 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, announced that it will continue to provide its e-commerce service to its platform members during the China Ministry of Commerce's 2022 Online L...

2022-01-28 22:00 3327

CLPS Incorporation Announces Chairman's Letter to the Company's Shareholders

HONG KONG, Jan. 28, 2022 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or "the Company"), today released a letter to shareholders from the Chairman of the Company's Board of Directors (the "Board"), the full text of which is provided below. All CLPS shareholders are encouraged to read...

2022-01-28 21:30 7617

Yili Holds Its Annual Meeting Online - Over RMB 1.2 Billion Worth of Employee Incentives Provided in 2021

* Last year, Yili embarked upon a new journey and achieved the best operating performance ever * Yili has achieved high-quality development and rewarded its employees, the industry chain and society HUHHOT, China, Jan. 28, 2022 /PRNewswire/ -- On January 25, 2022, Yili held its 2021 annual me...

2022-01-28 21:16 6556

Universiti Teknologi Malaysia Solar Energy Technology Transfer Projects Prospering Communities

JOHOR BAHRU, Malaysia, Jan. 28, 2022  /PRNewswire/ -- Recently, UTM's School of Electrical Engineering researchers have installed solar panels on fishing boats to replace the use of diesel mainly for environmental sustainability purpose. Universiti Teknologi Malaysia (UTM) is a research universit...

2022-01-28 21:08 6850

I-Mab Announces Partnership Agreement to Localize Manufacturing and Accelerate Commercialization of Innovative Biologics Drugs

SHANGHAI and GAITHERSBURG, Md., Jan. 28, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the signing of a partnership agreement with the Hangzhou Qian...

2022-01-28 21:00 3142

China Matters presents 'Zhongshan Efficiency'

BEIJING, Jan. 28, 2022 /PRNewswire/ -- What is 'Zhongshan Efficiency'? In Zhongshan City of Guangdong Province, it takes only five minutes to change the legal representative on a business license. It takes only 10 minutes for the government to solve problems for enterprises on a breakfast meeting...

2022-01-28 20:48 2905

Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare,Milano, focused on cardiovascular research, reports the first patient enrolment of theTRANSFORM II Randomized Controlled Trial (Sirolimus-coa...

2022-01-28 20:34 5278

First High-School Education Group's Voluntary Update on Operation

BEIJING, Jan. 28, 2022 /PRNewswire/ -- First High-School Education Group Co., Ltd. ("First High-School Education Group" or the "Company") (NYSE: FHS), an education service provider primarily focusing on high schools inWestern China, today announced its voluntary update on Company's business opera...

2022-01-28 20:30 6028

Skillful Craftsman to Acquire Controlling Interest of Major Flexible Staffing Platform in Jiangsu Province to Expand Online Business Presence Domestically

WUXI, China, Jan. 28, 2022 /PRNewswire/ -- Skillful Craftsman Education Technology Ltd. (the "Company") (NASDAQ: EDTK), an education technology company providing interactive online learning services, announced that onJanuary 28, 2022 the Company entered into an equity transfer agreement (the "Agr...

2022-01-28 20:30 5818

Euroclear group reports another record year and delivery of financial targets two years ahead of plan

Results for the Year Ending 31 December 2021 BRUSSELS, Jan. 28, 2022 /PRNewswire/ -- Highlights                   Full year revenue growth stronger than expected  * Operating income up +9% year-on-year * Business income up +15% year-on-year,  with operating metrics growing strongly - Asse...

2022-01-28 20:08 4413

Alterity Therapeutics Announces Publication Demonstrating that ATH434 is Neuroprotective in Animal Model of Parkinsonian Disorder in the Journal of Parkinson's Disease

MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that data in an animal model of Multiple S...

2022-01-28 20:08 2931